Showing results (251-260 of 3,366) with videos related to
Sort By:
Pageof 337
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.Journal of Clinical Microbiology|August 1, 1982
Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibilityR N Jones, A L Barry, J L Cotton, et al.The Journal of Antimicrobial Chemotherapy|January 1, 1996
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))D L Sewell, A L Barry, S D Allen, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactamM A Pfaller, A L Barry, P C Fuchs, et al.The Journal of Antimicrobial Chemotherapy|February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limitsA L Barry, P C Fuchs, S D Allen, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methodsP C Fuchs, A L Barry, F C Tenover, et al.Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.Journal of Clinical Microbiology|January 1, 1995
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628A L Barry, P C Fuchs, S D Allen, et al.Pageof 337